Compare · AAON vs TMO
AAON vs TMO
Side-by-side comparison of AAON Inc. (AAON) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AAON and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $174.52B, about 16.1x AAON ($10.82B).
- Over the past year, AAON is up 40.4% and TMO is up 14.9% - AAON leads by 25.5 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 11 for AAON).
- TMO has more recent analyst coverage (25 ratings vs 11 for AAON).
- Company
- AAON Inc.
- Thermo Fisher Scientific Inc
- Price
- $132.05-0.32%
- $469.56-0.67%
- Market cap
- $10.82B
- $174.52B
- 1M return
- +2.05%
- -1.03%
- 1Y return
- +40.45%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 11
- 17
- Recent ratings
- 11
- 25
AAON Inc.
AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada. It offers rooftop units, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, self-contained units, coils, and controls. The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, medical, and other commercial industries. It sells its products through a network of manufacturers' representatives and internal sales force. The company was incorporated in 1987 and is based in Tulsa, Oklahoma.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest AAON
- AAON Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Chief Accounting Officer Thompson Rebecca sold $606,667 worth of shares (4,230 units at $143.42) (SEC Form 4)
- Director Fields Gary D sold $2,663,800 worth of shares (19,000 units at $140.20), decreasing direct ownership by 55% to 15,252 units (SEC Form 4)
- Director Asbjornson Norman H gifted 189,441 shares (SEC Form 4)
- SEC Form SD filed by AAON Inc.
- Executive Vice President Wichman Gordon Douglas exercised 3,000 shares at a strike of $27.58 and sold $421,170 worth of shares (3,000 units at $140.39) (SEC Form 4)
- Director Fields Gary D exercised 21,173 shares at a strike of $48.91 and sold $2,971,419 worth of shares (21,173 units at $140.34) (SEC Form 4)
- AAON to Present at William Blair Growth Stock Conference
- Chief Financial Officer Cheung Chung Kin was granted 15,507 shares, increasing direct ownership by 762% to 17,541 units (SEC Form 4)
- AAON Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)